Core Alternative Capital’s CVS Health CVS Stock Holding History

Core Alternative Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.1K	Hold	266	–	–	0.01%	175
2025 Q4	$21.1K	Sell	266 -73	-22%	-$5.75K	0.01%	175
2025 Q3	$25.6K	Hold	339	–	–	0.01%	155
2025 Q2	$23.4K	Hold	339	–	–	0.01%	158
2025 Q1	$23K	Sell	339 -104	-23%	-$6.22K	0.01%	166
2024 Q4	$19.9K	Buy	443 +5	+1%	+$281	﹤0.01%	187
2024 Q3	$27.5K	Sell	438 -35,395	-99%	-$2.06M	0.01%	178
2024 Q2	$2.12M	Sell	35,833 -60,414	-63%	-$3.78M	0.42%	62
2024 Q1	$7.68M	Sell	96,247 -16,087	-14%	-$1.23M	1.38%	34
2023 Q4	$8.87M	Sell	112,334 -23,717	-17%	-$1.69M	1.52%	30
2023 Q3	$9.5M	Buy	136,051 +28,184	+26%	+$2M	1.47%	33
2023 Q2	$7.46M	Sell	107,867 -8,397	-7%	-$597K	1.09%	41
2023 Q1	$8.64M	Buy	116,264 +87,657	+306%	+$7.35M	1.15%	41
2022 Q4	$2.67M	Buy	28,607 +3,214	+13%	+$310K	0.34%	51
2022 Q3	$2.42M	Buy	25,393 +4,954	+24%	+$490K	0.39%	46
2022 Q2	$1.89M	Buy	20,439 +9,093	+80%	+$887K	0.45%	46
2022 Q1	$1.15M	Buy	11,346 +9,637	+564%	+$1.01M	0.31%	48
2021 Q4	$176K	Buy	+1,709	New	+$158K	0.04%	86

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Core Alternative Capital's CVS Position: Q1 2026 in Review

Core Alternative Capital held its CVS Health (CVS) position steady in Q1 2026 at 266 shares worth $19.1K. The position accounts for 0.01% of the portfolio, ranked #175.

Core Alternative Capital first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.5M in Q3 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Core Alternative Capital held 266 shares of CVS Health worth $19.1K as of Q1 2026.
Core Alternative Capital left its CVS Health share count unchanged in Q1 2026.
CVS Health made up 0.01% of Core Alternative Capital's portfolio in Q1 2026, its #175 holding.
Core Alternative Capital first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
Core Alternative Capital's CVS Health position peaked at $9.5M in Q3 2023.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Core Alternative Capital's 13F filing for Q1 2026, filed 30 Apr 2026.